Combination therapy for painful diabetic neuropathy is safe and effective
BMJ · 2023
DOI: 10.1136/bmj.p866 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift BMJ, 2023. Verfasst von Helen Saul und 3 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Evidence, Twickenham, UK evidence@nihr.ac.uk. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 1 Literaturangaben.
Abstract (Originalsprache)
The study Tesfaye S, Sloan G, Petrie J, et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet 2022;400:680-90. To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/combination-therapy-for-painful-diabetic-neuropathy-is-safe-and-effective/
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- NIHR Evidence, Twickenham, UK evidence@nihr.ac.uk.
- NIHR Evidence, Twickenham, UK.
- University of Sheffield, Sheffield, UK.
Zitieren
APA
Saul, H., Deeney, B., Imison, C., & Tesfaye, S. (2023). Combination therapy for painful diabetic neuropathy is safe and effective. BMJ. https://doi.org/10.1136/bmj.p866
Vancouver
Saul H, Deeney B, Imison C, Tesfaye S. Combination therapy for painful diabetic neuropathy is safe and effective. BMJ. 2023. doi:10.1136/bmj.p866
BibTeX
@article{Saul2023,
author = {Saul, Helen and Deeney, Brendan and Imison, Candace and Tesfaye, Solomon},
title = {Combination therapy for painful diabetic neuropathy is safe and effective},
journal = {BMJ},
year = {2023},
doi = {10.1136/bmj.p866}
}
EUVIMED